Amgen CEO Robert Bradway's total compensation for 2023 was $22.6 million. This figure marks an increase from his 2022 earnings.
Amgen CEO Robert Bradway's Compensation Details
Robert Bradway, the chief executive officer of Amgen, saw a notable increase in his overall compensation last year. For the year 2023, his total pay amounted to $22.6 million. This represents a 5.8% increase compared to his total compensation of $21.4 million in 2022.
A primary factor contributing to this increase in Bradway's compensation was the company's significant acquisition of Horizon Therapeutics. This strategic move played a key role in boosting his overall pay for the year.
Annual Total Pay Comparison
The table below illustrates the total compensation for Amgen's CEO over the past two years:
| Year | Total Pay (in millions) |
|---|---|
| 2023 | $22.6 |
| 2022 | $21.4 |
This data reflects the reported figures for Robert Bradway's total pay package, highlighting the increment influenced by the company's strategic growth through acquisitions.
